1. Economic Evaluation Techniques in Healthcare

   • Alan Maynard

   Current Opinion 01 December 2012 Pages: 115 - 118

2. The Role of the US Food and Drug Administration’s Patient Information Initiative in Cost-Effective Drug Therapy

   • Stuart Nightingale
   • Thomas J. McGinnis

   Leading Article 01 December 2012 Pages: 119 - 125

3. The Economics of Osteoporosis and Its Prevention

   • David J. Torgerson
   • David M. Reid

   Review Article 01 December 2012 Pages: 126 - 138

4. Erratum to A case for the adoption of pharmacoeconomic guidelines in Japan

   • Ikeda

   Erratum 01 December 2012 Pages: 138 - 138

5. The Economics of Pharmacotherapy for Diabetes Mellitus

   • Bernardo Costa
   • Jaume Arroyo
   • Angels Sabaté

   Review Article 01 December 2012 Pages: 139 - 158

6. Guidelines for Pharmacoeconomic Studies

   • Joanna E. Siegel
   • George W. Torrance
   • the members of the Panel on Cost Effectiveness in Health and Medicine

   Special Article 01 December 2012 Pages: 159 - 168

7. An Economic Evaluation of the Use of Granulocyte Colony-Stimulating Factor After Bone Marrow Transplantation in Children

   • Nicholas Duncan
   • Margaret Hewetson
   • Ross Pinkerton

   Original Research Article 01 December 2012 Pages: 169 - 174

8. Differences in the Methodology and Data of Economic Evaluations of a Health Programme

   • Xavier Badia
   • Gonzalo Nocea
   • Joan Rovira

   Original Research Article 01 December 2012 Pages: 175 - 183

9. Terazosin

   • Greg L. Plosker
   • Karen L. Goa

   Adis Pharmacoeconomic Drug Evaluation 01 December 2012 Pages: 184 - 197

10. Glossary

    News 01 December 2012 Pages: 198 - 201